In this edition of The Motley Fool's Market Checkup, health-care analysts David Williamson and Max Macaluso discuss the complex nuances of the type 2 diabetes market. From the most successful blockbusters on the market today to revolutionary experimental drugs, this is an increasingly competitive space that investors need to watch closely.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.